Risk of drug resistance in repeat gram-negative infections among patients with multiple hospitalizations
- PMID: 28946105
- PMCID: PMC5732868
- DOI: 10.1016/j.jcrc.2017.09.033
Risk of drug resistance in repeat gram-negative infections among patients with multiple hospitalizations
Abstract
Purpose: Drug resistance in gram-negative bacterial hospital-acquired infections (GNB HAIs) has become ubiquitous in recent years. Patients who experience multiple hospitalizations are at high risk of developing repeat GNB HAIs. This study aims to evaluate the relationship between repeat GNB HAIs and antibiotic susceptibility patterns.
Methods: Using electronic medical records from three hospitals, 4053 patients were identified with at least one HAI caused by K. pneumoniae or P. aeruginosa over multiple hospitalizations in a 9-year period. Modified Poisson regression was used to evaluate the risk of drug resistance with increasing number of prior susceptible infections. Drug resistance was defined as resistant to carbapenems for K. pneumoniae and resistant to levofloxacin for P. aeruginosa.
Results: In patients with repeat infections, almost 15% of consecutive infections changed from susceptible to drug-resistant. Patients with K. pneumoniae infections had a 1.14 times increased risk of acquiring a drug-resistant HAI with each prior HAI, after adjusting for potential confounders and antibiotic use prior to infection. Patients with P. aeruginosa infections had a 1.23 times increased risk of a drug-resistant infection with each prior P. aeruginosa HAI.
Conclusions: Prevention of repeat infections in high healthcare utilizers may be important in reducing drug resistance in this population.
Keywords: Drug resistance; Gram-negative infection; Hospital-acquired infection; Repeat infection.
Copyright © 2017 Elsevier Inc. All rights reserved.
Figures
Similar articles
-
Carbapenem-resistant gram-negative bacterial infections and risk factors for acquisition in a Kenyan intensive care unit.BMC Infect Dis. 2024 May 23;24(1):522. doi: 10.1186/s12879-024-09256-6. BMC Infect Dis. 2024. PMID: 38783175 Free PMC article.
-
Risk factors and outcomes of infections caused by extremely drug-resistant gram-negative bacilli in patients hospitalized in intensive care units.Am J Infect Control. 2014 Jun;42(6):626-31. doi: 10.1016/j.ajic.2014.01.027. Epub 2014 Apr 13. Am J Infect Control. 2014. PMID: 24725516 Free PMC article.
-
Influence of antimicrobial consumption on gram-negative bacteria in inpatients receiving antimicrobial resistance therapy from 2008-2013 at a tertiary hospital in Shanghai, China.Am J Infect Control. 2015 Apr 1;43(4):358-64. doi: 10.1016/j.ajic.2014.12.010. Am J Infect Control. 2015. PMID: 25838134
-
Emerging issues in the management of infections caused by multidrug-resistant gram-negative bacteria.Cleve Clin J Med. 2007 Aug;74 Suppl 4:S12-20. doi: 10.3949/ccjm.74.suppl_4.s12. Cleve Clin J Med. 2007. PMID: 17847174 Review.
-
Evaluation of colistin as an agent against multi-resistant Gram-negative bacteria.Int J Antimicrob Agents. 2005 Jan;25(1):11-25. doi: 10.1016/j.ijantimicag.2004.10.001. Int J Antimicrob Agents. 2005. PMID: 15620821 Review.
Cited by
-
Antibiotic Resistance to Pseudomonas Aeruginosa in the Saliva of Candidates of Bone Marrow Transplantation.J Dent (Shiraz). 2025 Mar 1;26(1):17-24. doi: 10.30476/dentjods.2024.100492.2225. eCollection 2025 Mar. J Dent (Shiraz). 2025. PMID: 40092546 Free PMC article.
-
Risk Factors of Infections Due to Multidrug-Resistant Gram-Negative Bacteria in a Community Hospital in Rural Thailand.Trop Med Infect Dis. 2022 Oct 23;7(11):328. doi: 10.3390/tropicalmed7110328. Trop Med Infect Dis. 2022. PMID: 36355871 Free PMC article.
-
A Decision Tree Using Patient Characteristics to Predict Resistance to Commonly Used Broad-Spectrum Antibiotics in Children With Gram-Negative Bloodstream Infections.J Pediatric Infect Dis Soc. 2020 Apr 30;9(2):142-149. doi: 10.1093/jpids/piy137. J Pediatric Infect Dis Soc. 2020. PMID: 30690525 Free PMC article.
-
Ceftazidime/Avibactam and Ceftolozane/Tazobactam for Multidrug-Resistant Gram Negatives in Patients with Hematological Malignancies: Current Experiences.Antibiotics (Basel). 2020 Feb 3;9(2):58. doi: 10.3390/antibiotics9020058. Antibiotics (Basel). 2020. PMID: 32028615 Free PMC article. Review.
-
Trends, Epidemiology, and Management of Multi-Drug Resistant Gram-Negative Bacterial Infections in the Hospitalized Setting.Antibiotics (Basel). 2020 Apr 20;9(4):196. doi: 10.3390/antibiotics9040196. Antibiotics (Basel). 2020. PMID: 32326058 Free PMC article. Review.
References
-
- Centers for Disease Control Prevention. National and State Healthcare Associated Infections Progress Report. Atlanta, GA: Centers for Disease Control and Prevention; 2014.
-
- World Health Organization. Antimicrobial Resistance: 2014 Global Report on Surveillance. World Health Organization; 2014.
-
- MacVane SH, Tuttle LO, Nicolau DP. Impact of extended-spectrum beta-lactamase-producing organisms on clinical and economic outcomes in patients with urinary tract infection. J Hosp Med. 2014;9(4):232–8. - PubMed
-
- Vardakas KZ, Rafailidis PI, Konstantelias AA, Falagas ME. Predictors of mortality in patients with infections due to multi-drug resistant Gram negative bacteria: the study, the patient, the bug or the drug? J Infect. 2013;66(5):401–14. - PubMed
-
- Wang W, Jiang T, Zhang W, Li C, Chen J, Xiang D, et al. Predictors of mortality in bloodstream infections caused by multidrug-resistant gram-negative bacteria: 4 years of collection. Am J Infect Control. 2017;45(1):59–64. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical